{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T18:23:49Z","timestamp":1778005429328,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T00:00:00Z","timestamp":1534723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2017\/01\/X\/NZ2\/01906"],"award-info":[{"award-number":["2017\/01\/X\/NZ2\/01906"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004569","name":"Ministerstwo Nauki i Szkolnictwa Wy\u017cszego","doi-asserted-by":"publisher","award":["5536\/E-63\/SPUB\/2017\/1"],"award-info":[{"award-number":["5536\/E-63\/SPUB\/2017\/1"]}],"id":[{"id":"10.13039\/501100004569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008648","name":"Krajowy Naukowy Osrodek Wiodacy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008648","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12967-018-1608-2","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T08:37:25Z","timestamp":1534754245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-6877","authenticated-orcid":false,"given":"Luiza","family":"Handschuh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Wojciechowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maciej","family":"Kazmierczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Marcinkowska-Swojak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Luczak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof","family":"Lewandowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieczyslaw","family":"Komarnicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacek","family":"Blazewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Figlerowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piotr","family":"Kozlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,20]]},"reference":[{"key":"1608_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-0-387-69259-3_9","volume":"145","author":"B Falini","year":"2010","unstructured":"Falini B. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features. Cancer Treat Res. 2010;145:149\u201368. \n                    https:\/\/doi.org\/10.1007\/978-0-387-69259-3_9\n                    \n                  .","journal-title":"Cancer Treat Res"},{"key":"1608_CR2","doi-asserted-by":"publisher","first-page":"195209","DOI":"10.1155\/2011\/195209","volume":"2011","author":"MS Lindstr\u00f6m","year":"2011","unstructured":"Lindstr\u00f6m MS. NPM1\/B23: a multifunctional chaperone in ribosome biogenesis and chromatin remodeling. Biochem Res Int. 2011;2011:195209. \n                    https:\/\/doi.org\/10.1155\/2011\/195209\n                    \n                  .","journal-title":"Biochem Res Int."},{"key":"1608_CR3","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1182\/blood-2006-07-012252","volume":"109","author":"B Falini","year":"2007","unstructured":"Falini B, Nicoletti I, Martelli MF, Mecucci C. Acute myeloid leukemia carrying cytoplasmic\/mutated nucleophosmin (NPMc\u2009+\u2009AML): biologic and clinical features. Blood. 2007;109:874\u201385. \n                    https:\/\/doi.org\/10.1182\/blood-2006-07-012252\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR4","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1043\/1543-2165(2006)130[1687:NGMIAM]2.0.CO;2","volume":"130","author":"W Chen","year":"2006","unstructured":"Chen W, Rassidakis GZ, Medeiros LJ. Nucleophosmin gene mutations in acute myeloid leukemia. Arch Pathol Lab Med. 2006;130:1687\u201392. \n                    https:\/\/doi.org\/10.1043\/1543-2165(2006)130[1687:NGMIAM]2.0.CO;2\n                    \n                  .","journal-title":"Arch Pathol Lab Med"},{"key":"1608_CR5","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","volume":"352","author":"B Falini","year":"2005","unstructured":"Falini B, Mecucci C, Tiacci E, Alcalay M, Rosati R, Pasqualucci L, La Starza R, Diverio D, Colombo E, Santucci A, Bigerna B, Pacini R, Pucciarini A, et al. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype. N Engl J Med. 2005;352:254\u201366. \n                    https:\/\/doi.org\/10.1056\/NEJMoa041974\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"1608_CR6","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1182\/blood-2005-02-0560","volume":"106","author":"M Alcalay","year":"2005","unstructured":"Alcalay M, Tiacci E, Bergomas R, Bigerna B, Venturini E, Minardi SP, Meani N, Diverio D, Bernard L, Tizzoni L, Volorio S, Luzi L, Colombo E, et al. Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc\u2009+\u2009AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance. Blood. 2005;106:899\u2013902. \n                    https:\/\/doi.org\/10.1182\/blood-2005-02-0560\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1200\/JCO.2009.25.1496","volume":"28","author":"H Becker","year":"2010","unstructured":"Becker H, Marcucci G, Maharry K, Radmacher MD, Mr\u00f3zek K, Margeson D, Whitman SP, Wu Y-Z, Schwind S, Paschka P, Powell BL, Carter TH, Kolitz JE, et al. Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study. J Clin Oncol. 2010;28:596\u2013604. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.25.1496\n                    \n                  .","journal-title":"J Clin Oncol"},{"key":"1608_CR8","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1182\/blood-2009-01-197871","volume":"114","author":"C Haferlach","year":"2009","unstructured":"Haferlach C, Mecucci C, Schnittger S, Kohlmann A, Mancini M, Cuneo A, Testoni N, Rege-Cambrin G, Santucci A, Vignetti M, Fazi P, Martelli MP, Haferlach T, et al. AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features. Blood. 2009;114:3024\u201332. \n                    https:\/\/doi.org\/10.1182\/blood-2009-01-197871\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.leukres.2012.11.008","volume":"37","author":"T Alpermann","year":"2013","unstructured":"Alpermann T, Kern W, Schnittger S, Schmid C, Kreuzer K-A, Serve H, Pielken HJ, Schmitz N, Wendtner C-M, Haferlach C, Haferlach T. Evaluation of the proposed reporting system of the European LeukemiaNet and recommendations for prognosis of acute myeloid leukemia. Leuk Res. 2013;37:197\u2013200. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2012.11.008\n                    \n                  .","journal-title":"Leuk Res"},{"key":"1608_CR10","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1182\/blood-2005-05-2164","volume":"106","author":"K D\u00f6hner","year":"2005","unstructured":"D\u00f6hner K, Schlenk RF, Habdank M, Scholl C, R\u00fccker FG, Corbacioglu A, Bullinger L, Fr\u00f6hling S, D\u00f6hner H. Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations. Blood. 2005;106:3740\u20136. \n                    https:\/\/doi.org\/10.1182\/blood-2005-05-2164\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR11","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2005-06-2248","volume":"106","author":"S Schnittger","year":"2005","unstructured":"Schnittger S, Schoch C, Kern W, Mecucci C, Tschulik C, Martelli MF, Haferlach T, Hiddemann W, Falini B. Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype. Blood. 2005;106:3733\u20139. \n                    https:\/\/doi.org\/10.1182\/blood-2005-06-2248\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR12","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","volume":"127","author":"DA Arber","year":"2016","unstructured":"Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, Bloomfield CD, Cazzola M, Vardiman JW. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127:2391\u2013405. \n                    https:\/\/doi.org\/10.1182\/blood-2016-03-643544\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","volume":"114","author":"JW Vardiman","year":"2009","unstructured":"Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, Harris NL, Le Beau MM, Hellstr\u00f6m-Lindberg E, Tefferi A, Bloomfield CD. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114:937\u201351. \n                    https:\/\/doi.org\/10.1182\/blood-2009-03-209262\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR14","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/sj.leu.2403846","volume":"19","author":"NI Noguera","year":"2005","unstructured":"Noguera NI, Ammatuna E, Zangrilli D, Lavorgna S, Divona M, Buccisano F, Amadori S, Mecucci C, Falini B, Lo-Coco F. Simultaneous detection of NPM1 and FLT3-ITD mutations by capillary electrophoresis in acute myeloid leukemia. Leukemia. 2005;19:1479\u201382. \n                    https:\/\/doi.org\/10.1038\/sj.leu.2403846\n                    \n                  .","journal-title":"Leukemia"},{"key":"1608_CR15","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.leukres.2006.12.011","volume":"31","author":"S Scholl","year":"2007","unstructured":"Scholl S, M\u00fcgge L-O, Landt O, Loncarevic IF, Kunert C, Clement JH, H\u00f6ffken K. Rapid screening and sensitive detection of NPM1 (nucleophosmin) exon 12 mutations in acute myeloid leukaemia. Leuk Res. 2007;31:1205\u201311. \n                    https:\/\/doi.org\/10.1016\/j.leukres.2006.12.011\n                    \n                  .","journal-title":"Leuk Res"},{"key":"1608_CR16","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1182\/blood-2010-01-266908","volume":"116","author":"AM Gruszka","year":"2010","unstructured":"Gruszka AM, Lavorgna S, Consalvo MI, Ottone T, Martinelli C, Cinquanta M, Ossolengo G, Pruneri G, Buccisano F, Divona M, Cedrone M, Ammatuna E, Venditti A, et al. A monoclonal antibody against mutated nucleophosmin 1 for the molecular diagnosis of acute myeloid leukemias. Blood. 2010;116:2096\u2013102. \n                    https:\/\/doi.org\/10.1182\/blood-2010-01-266908\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR17","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00277-012-1617-9","volume":"92","author":"E Oppliger Leibundgut","year":"2013","unstructured":"Oppliger Leibundgut E, Porret NA, Bienz Muggli M, Baumgartner H, Dahlhaus M, Baerlocher GM. Rapid and highly specific screening for NPM1 mutations in acute myeloid leukemia. Ann Hematol. 2013;92:173\u20137. \n                    https:\/\/doi.org\/10.1007\/s00277-012-1617-9\n                    \n                  .","journal-title":"Ann Hematol"},{"key":"1608_CR18","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.mrfmmm.2016.02.001","volume":"786","author":"M Marcinkowska-Swojak","year":"2016","unstructured":"Marcinkowska-Swojak M, Handschuh L, Wojciechowski P, Goralski M, Tomaszewski K, Kazmierczak M, Lewandowski K, Komarnicki M, Blazewicz J, Figlerowicz M, Kozlowski P. Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification. Mutat Res. 2016;786:14\u201326. \n                    https:\/\/doi.org\/10.1016\/j.mrfmmm.2016.02.001\n                    \n                  .","journal-title":"Mutat Res"},{"key":"1608_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1309\/AJCPIDKDLSGE26CX","volume":"141","author":"AP Londero","year":"2014","unstructured":"Londero AP, Orsaria M, Tell G, Marzinotto S, Capodicasa V, Poletto M, Vascotto C, Sacco C, Mariuzzi L. Expression and prognostic significance of APE1\/Ref-1 and NPM1 proteins in high-grade ovarian serous cancer. Am J Clin Pathol. 2014;141:404\u201314. \n                    https:\/\/doi.org\/10.1309\/AJCPIDKDLSGE26CX\n                    \n                  .","journal-title":"Am J Clin Pathol"},{"key":"1608_CR20","doi-asserted-by":"publisher","first-page":"e96293","DOI":"10.1371\/journal.pone.0096293","volume":"9","author":"G Loubeau","year":"2014","unstructured":"Loubeau G, Boudra R, Maquaire S, Lours-Calet C, Beaudoin C, Verrelle P, Morel L. NPM1 silencing reduces tumour growth and MAPK signalling in prostate cancer cells. PLoS ONE. 2014;9:e96293. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0096293\n                    \n                  .","journal-title":"PLoS ONE"},{"key":"1608_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1423-0127-19-53","volume":"19","author":"Y Liu","year":"2012","unstructured":"Liu Y, Zhang F, Zhang X-F, Qi L-S, Yang L, Guo H, Zhang N. Expression of nucleophosmin\/NPM1 correlates with migration and invasiveness of colon cancer cells. J Biomed Sci. 2012;19:53. \n                    https:\/\/doi.org\/10.1186\/1423-0127-19-53\n                    \n                  .","journal-title":"J Biomed Sci"},{"key":"1608_CR22","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1002\/ijc.28180","volume":"133","author":"JCT Wong","year":"2013","unstructured":"Wong JCT, Hasan MR, Rahman M, Yu AC, Chan SK, Schaeffer DF, Kennecke HF, Lim HJ, Owen D, Tai IT. Nucleophosmin 1, upregulated in adenomas and cancers of the colon, inhibits p53-mediated cellular senescence. Int J Cancer J Int Cancer. 2013;133:1567\u201377. \n                    https:\/\/doi.org\/10.1002\/ijc.28180\n                    \n                  .","journal-title":"Int J Cancer J Int Cancer."},{"key":"1608_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1745-7254.2008.00747.x","volume":"29","author":"K Tsui","year":"2008","unstructured":"Tsui K, Juang H, Lee T, Chang P, Chen C, Yung BY. Association of nucleophosmin\/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples. Acta Pharmacol Sin. 2008;29:364\u201370. \n                    https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00747.x\n                    \n                  .","journal-title":"Acta Pharmacol Sin"},{"key":"1608_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.bbrc.2010.05.142","volume":"397","author":"A Pianta","year":"2010","unstructured":"Pianta A, Puppin C, Franzoni A, Fabbro D, Di Loreto C, Bulotta S, Deganuto M, Paron I, Tell G, Puxeddu E, Filetti S, Russo D, Damante G. Nucleophosmin is overexpressed in thyroid tumors. Biochem Biophys Res Commun. 2010;397:499\u2013504. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2010.05.142\n                    \n                  .","journal-title":"Biochem Biophys Res Commun"},{"key":"1608_CR25","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.yexcr.2010.12.013","volume":"317","author":"CK Kim","year":"2011","unstructured":"Kim CK, Nguyen TLX, Lee SB, Park SB, Lee K-H, Cho S-W, Ahn J-Y. Akt2 and nucleophosmin\/B23 function as an oncogenic unit in human lung cancer cells. Exp Cell Res. 2011;317:966\u201375. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2010.12.013\n                    \n                  .","journal-title":"Exp Cell Res"},{"key":"1608_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1021\/bi00429a017","volume":"28","author":"WY Chan","year":"1989","unstructured":"Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry. 1989;28:1033\u20139.","journal-title":"Biochemistry"},{"key":"1608_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/sj.bjc.6603574","volume":"96","author":"J-P Yun","year":"2007","unstructured":"Yun J-P, Miao J, Chen GG, Tian Q-H, Zhang C-Q, Xiang J, Fu J, Lai PBS. Increased expression of nucleophosmin\/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. Br J Cancer. 2007;96:477\u201384. \n                    https:\/\/doi.org\/10.1038\/sj.bjc.6603574\n                    \n                  .","journal-title":"Br J Cancer"},{"key":"1608_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0165-2478(02)00085-8","volume":"83","author":"NN Dergunova","year":"2002","unstructured":"Dergunova NN, Bulycheva TI, Artemenko EG, Shpakova AP, Pegova AN, Gemjian EG, Dudnik OA, Zatsepina OV, Malashenko OS. A major nucleolar protein B23 as a marker of proliferation activity of human peripheral lymphocytes. Immunol Lett. 2002;83:67\u201372.","journal-title":"Immunol Lett"},{"key":"1608_CR29","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/sj.onc.1201286","volume":"15","author":"T Kondo","year":"1997","unstructured":"Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T, Tanaka N. Identification and characterization of nucleophosmin\/B23\/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene. 1997;15:1275\u201381. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1201286\n                    \n                  .","journal-title":"Oncogene"},{"key":"1608_CR30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3892\/ijo.2017.4233","volume":"52","author":"L Handschuh","year":"2018","unstructured":"Handschuh L, Ka\u017amierczak M, Milewski MC, G\u00f3ralski M, \u0141uczak M, Wojtaszewska M, Uszczy\u0144ska-Ratajczak B, Lewandowski K, Komarnicki M, Figlerowicz M. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR. Int J Oncol. 2018;52:656\u201378. \n                    https:\/\/doi.org\/10.3892\/ijo.2017.4233\n                    \n                  .","journal-title":"Int J Oncol"},{"key":"1608_CR31","doi-asserted-by":"publisher","first-page":"95163\u201375","DOI":"10.18632\/oncotarget.19871","volume":"8","author":"M Zajac","year":"2017","unstructured":"Zajac M, Dolnik A, Stasiak G, Zaleska J, Kielbus M, Czapinski J, Schunn M, Correa SC, Glodkowska-Mrowka E, Sundaram RC, Jankowska-Lecka O, Schlenk RF, D\u00f6hner H, et al. Analysis of NPM1 splice variants reveals differential expression patterns of prognostic value in acute myeloid leukemia. Oncotarget. 2017;8:95163\u201375. \n                    https:\/\/doi.org\/10.18632\/oncotarget.19871\n                    \n                  .","journal-title":"Oncotarget."},{"key":"1608_CR32","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/nar\/gkt897","volume":"42","author":"M Hisaoka","year":"2014","unstructured":"Hisaoka M, Nagata K, Okuwaki M. Intrinsically disordered regions of nucleophosmin\/B23 regulate its RNA binding activity through their inter- and intra-molecular association. Nucleic Acids Res. 2014;42:1180\u201395. \n                    https:\/\/doi.org\/10.1093\/nar\/gkt897\n                    \n                  .","journal-title":"Nucleic Acids Res"},{"key":"1608_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12867-016-0073-9","volume":"17","author":"JK Box","year":"2016","unstructured":"Box JK, Paquet N, Adams MN, Boucher D, Bolderson E, O\u2019Byrne KJ, Richard DJ. Nucleophosmin: from structure and function to disease development. BMC Mol Biol. 2016;17:19. \n                    https:\/\/doi.org\/10.1186\/s12867-016-0073-9\n                    \n                  .","journal-title":"BMC Mol Biol"},{"key":"1608_CR34","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2009-07-235358","volume":"115","author":"H D\u00f6hner","year":"2010","unstructured":"D\u00f6hner H, Estey EH, Amadori S, Appelbaum FR, B\u00fcchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood. 2010;115:453\u201374. \n                    https:\/\/doi.org\/10.1182\/blood-2009-07-235358\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, Vessella RL, Tewari M. Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods. 2013;10:1003\u20135. \n                    https:\/\/doi.org\/10.1038\/nmeth.2633\n                    \n                  .","journal-title":"Nat Methods"},{"key":"1608_CR36","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/wrna.1276","volume":"6","author":"B Cieply","year":"2015","unstructured":"Cieply B, Carstens RP. Functional roles of alternative splicing factors in human disease: functional roles of alternative splicing factors in human disease. Wiley Interdiscip Rev RNA. 2015;6:311\u201326. \n                    https:\/\/doi.org\/10.1002\/wrna.1276\n                    \n                  .","journal-title":"Wiley Interdiscip Rev RNA."},{"key":"1608_CR37","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrc1885","volume":"6","author":"S Grisendi","year":"2006","unstructured":"Grisendi S, Mecucci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Nat Rev Cancer. 2006;6:493\u2013505. \n                    https:\/\/doi.org\/10.1038\/nrc1885\n                    \n                  .","journal-title":"Nat Rev Cancer."},{"key":"1608_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrc1015","volume":"3","author":"D Ruggero","year":"2003","unstructured":"Ruggero D, Pandolfi PP. Does the ribosome translate cancer? Nat Rev Cancer. 2003;3:179\u201392. \n                    https:\/\/doi.org\/10.1038\/nrc1015\n                    \n                  .","journal-title":"Nat Rev Cancer"},{"key":"1608_CR39","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3892\/ijo.2014.2407","volume":"45","author":"D-H Xu","year":"2014","unstructured":"Xu D-H, Liu F, Li X, Chen X-F, Jing G-J, Wu F-Y, Shi S-L, Li Q-F. Regulatory role of nucleophosmin during the differentiation of human liver cancer cells. Int J Oncol. 2014;45:264\u201372. \n                    https:\/\/doi.org\/10.3892\/ijo.2014.2407\n                    \n                  .","journal-title":"Int J Oncol"},{"key":"1608_CR40","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/1472-6882-12-185","volume":"12","author":"S Duangmano","year":"2012","unstructured":"Duangmano S, Sae-Lim P, Suksamrarn A, Domann FE, Patmasiriwat P. Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin\/B23 translocation. BMC Complement Altern Med. 2012;12:185. \n                    https:\/\/doi.org\/10.1186\/1472-6882-12-185\n                    \n                  .","journal-title":"BMC Complement Altern Med."},{"key":"1608_CR41","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000338941","volume":"35","author":"J Liu","year":"2012","unstructured":"Liu J, Huang B, Xiao Y, Xiong H-M, Li J, Feng D-Q, Chen X-M, Zhang H-B, Wang X-Z. Aberrant expression of splicing factors in newly diagnosed acute myeloid leukemia. Onkologie. 2012;35:335\u201340. \n                    https:\/\/doi.org\/10.1159\/000338941\n                    \n                  .","journal-title":"Onkologie."},{"key":"1608_CR42","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/pro.2240","volume":"22","author":"L Federici","year":"2013","unstructured":"Federici L, Falini B. Nucleophosmin mutations in acute myeloid leukemia: a tale of protein unfolding and mislocalization. Protein Sci. 2013;22:545\u201356. \n                    https:\/\/doi.org\/10.1002\/pro.2240\n                    \n                  .","journal-title":"Protein Sci"},{"key":"1608_CR43","doi-asserted-by":"publisher","first-page":"2854","DOI":"10.1182\/blood-2005-04-1733","volume":"106","author":"T Suzuki","year":"2005","unstructured":"Suzuki T, Kiyoi H, Ozeki K, Tomita A, Yamaji S, Suzuki R, Kodera Y, Miyawaki S, Asou N, Kuriyama K, Yagasaki F, Shimazaki C, Akiyama H, et al. Clinical characteristics and prognostic implications of NPM1 mutations in acute myeloid leukemia. Blood. 2005;106:2854\u201361. \n                    https:\/\/doi.org\/10.1182\/blood-2005-04-1733\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR44","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/sj.onc.1210942","volume":"27","author":"L L\u00e9otoing","year":"2008","unstructured":"L\u00e9otoing L, Meunier L, Manin M, Mauduit C, Decaussin M, Verrijdt G, Claessens F, Benahmed M, Veyssi\u00e8re G, Morel L, Beaudoin C. Influence of nucleophosmin\/B23 on DNA binding and transcriptional activity of the androgen receptor in prostate cancer cell. Oncogene. 2008;27:2858\u201367. \n                    https:\/\/doi.org\/10.1038\/sj.onc.1210942\n                    \n                  .","journal-title":"Oncogene"},{"key":"1608_CR45","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3892\/mmr.2016.6033","volume":"15","author":"H Wang","year":"2017","unstructured":"Wang H, Yuan G, Zhao B, Zhao Y, Qiu Y. High expression of B23 is associated with tumorigenesis and poor prognosis in bladder urothelial carcinoma. Mol Med Rep. 2017;15:743\u20139. \n                    https:\/\/doi.org\/10.3892\/mmr.2016.6033\n                    \n                  .","journal-title":"Mol Med Rep."},{"key":"1608_CR46","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/apm.12604","volume":"124","author":"F Zhou","year":"2016","unstructured":"Zhou F, Chen E, You D, Song Y, Sun Z, Yue L. Both high expression of nucleophosmin\/B23 and CRM1 predicts poorer prognosis in human gastric cancer. APMIS Acta Pathol Microbiol Immunol Scand. 2016;124:1046\u201353. \n                    https:\/\/doi.org\/10.1111\/apm.12604\n                    \n                  .","journal-title":"APMIS Acta Pathol Microbiol Immunol Scand."},{"key":"1608_CR47","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.bbrc.2015.08.118","volume":"466","author":"J Chen","year":"2015","unstructured":"Chen J, Sun J, Yang L, Yan Y, Shi W, Shi J, Huang Q, Chen J, Lan Q. Upregulation of B23 promotes tumor cell proliferation and predicts poor prognosis in glioma. Biochem Biophys Res Commun. 2015;466:124\u201330. \n                    https:\/\/doi.org\/10.1016\/j.bbrc.2015.08.118\n                    \n                  .","journal-title":"Biochem Biophys Res Commun"},{"key":"1608_CR48","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1182\/blood-2005-05-2174","volume":"106","author":"N Boissel","year":"2005","unstructured":"Boissel N, Renneville A, Biggio V, Philippe N, Thomas X, Cayuela J-M, Terre C, Tigaud I, Castaigne S, Raffoux E, De Botton S, Fenaux P, Dombret H, et al. Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype. Blood. 2005;106:3618\u201320. \n                    https:\/\/doi.org\/10.1182\/blood-2005-05-2174\n                    \n                  .","journal-title":"Blood"},{"key":"1608_CR49","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1200\/JCO.2009.27.3730","volume":"28","author":"G Marcucci","year":"2010","unstructured":"Marcucci G, Maharry K, Wu Y-Z, Radmacher MD, Mr\u00f3zek K, Margeson D, Holland KB, Whitman SP, Becker H, Schwind S, Metzeler KH, Powell BL, Carter TH, et al. IDH1 and IDH2 gene mutations identify novel molecular subsets within de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol. 2010;28:2348\u201355. \n                    https:\/\/doi.org\/10.1200\/JCO.2009.27.3730\n                    \n                  .","journal-title":"J Clin Oncol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12967-018-1608-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-018-1608-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T14:55:37Z","timestamp":1569336937000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-018-1608-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1608"],"URL":"https:\/\/doi.org\/10.1186\/s12967-018-1608-2","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,20]]},"assertion":[{"value":"17 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"232"}}